Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Oncology Reports|July 6, 2006
Nutraceutical inhibitors of urokinase: potential applications in prostate cancer prevention and treatmentJerzy Jankun, Steven H Selman, Jacek Aniola, et al.
International Journal of Molecular Medicine|February 13, 2003
Spatial distribution of liposome encapsulated tin etiopurpurin dichloride (SnET2) in the canine prostate: implications for computer simulation of photodynamic therapyJacek Aniola, Steven H Selman, Lothar Lilge, et al.
International Journal of Molecular Medicine|June 7, 2003
Structure of curcumin in complex with lipoxygenase and its significance in cancerEwa Skrzypczak-Jankun, Kangjing Zhou, N Patrick McCabe, et al.
Oncology Reports|November 18, 2004
Plasminogen activator inhibitor type-1 mutants regulate angiogenesis of human umbilical and lung vascular endothelial cellsJoanna Chorostowska-Wynimko, Rafal Swiercz, Ewa Skrzypczak-Jankun, et al.
BJU International|November 17, 2009
Very long half-life plasminogen activator inhibitor type 1 reduces bleeding in a mouse modelJerzy Jankun, Steven H Selman, Rick W Keck, et al.
Molecular Cancer Therapeutics|January 21, 2003
A novel form of the plasminogen activator inhibitor created by cysteine mutations extends its half-life: relevance to cancer and angiogenesisJoanna Chorostowska-Wynimko, Rafal Swiercz, Ewa Skrzypczak-Jankun, et al.
The Journal of Urology|August 13, 2003
Inhibition of bladder tumor growth by the green tea derivative epigallocatechin-3-gallateJ Karl Kemberling, James A Hampton, Rick W Keck, et al.
International Journal of Oncology|December 9, 2004
In vivo and in vitro effect of baicalein on human prostate cancer cellsRanko Miocinovic, N Patrick McCabe, Rick W Keck, et al.
Pageof 3